T-Cell Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in Pune City, Maharashtra, India, established in 2025.
2025 Pune City, Maharashtra, India Active
Last Updated:
Access Report
About T-Cell Pharmaceuticals Private Limited

T-Cell Pharmaceuticals Private Limited, a active private limited company, was established on 16 July 2025 in Pune City, Maharashtra, India. it holds CIN: U46497PN2025PTC243949. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Formerly known as T-Cell Pharmaceuticals Private Limited. Its leadership includes Prashant Subhashchand Bamb (Director), Sharad Dnyandeo Ghodekar (Director). It holds ₹2.00 Cr open charges and no settled loans. It is based at Cts 1571, Office No 101, Erande Empire(M.Corp), Pune City, Maharashtra, 411030.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497PN2025PTC243949

  • Registration Number

    243949

  • Incorporation Date

    16 July 2025

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Months 9 Days
  • Open Charges ₹ 2.00 Cr
Company report

T-Cell Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into T-Cell Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at T-Cell Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Prashant Subhashchand Bamb Director 16 Jul 2025 Current
Sharad Dnyandeo Ghodekar Director 16 Jul 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of T-Cell Pharmaceuticals.
T-Cell Pharmaceuticals revenue growth over time
T-Cell Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of T-Cell Pharmaceuticals?

Unlock access to T-Cell Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹20,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 2.00 Cr
Latest Charge Details
Date Lender Amount Status
11 Dec 2025 Others ₹2.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at T-Cell Pharmaceuticals?

Unlock and access historical data on people associated with T-Cell Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of T-Cell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped T-Cell Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on T-Cell Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge with Others amounted to Rs. 20.00 M with Charge ID 101199308 was registered on 11 Dec 2025. was completed.

  • Director Appointment

    Progress on Prashant Subhashchand Bamb was appointed as a Director was appointed as a Director on 16 Jul 2025 & has been associated with this company since 7 months 9 days . was documented.

  • Director Appointment

    Progress on Sharad Dnyandeo Ghodekar was appointed as a Director was appointed as a Director on 16 Jul 2025 & has been associated with this company since 7 months 9 days . was documented.

  • Company Incorporation

    T-Cell Pharmaceuticals Private Limited was registered on 16 Jul 2025 with Roc Pune & aged 7 months 9 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of T-Cell Pharmaceuticals Private Limited?

The CIN of T-Cell Pharmaceuticals Private Limited is U46497PN2025PTC243949.

Where is T-Cell Pharmaceuticals Private Limited headquartered?

T-Cell Pharmaceuticals Private Limited is headquartered at Cts 1571, Office No 101, Erande Empire(M.Corp), Pune City, Maharashtra, 411030.

When was T-Cell Pharmaceuticals Private Limited incorporated?

T-Cell Pharmaceuticals Private Limited was incorporated on 16 July 2025.

Who are the current directors of T-Cell Pharmaceuticals Private Limited?

The current directors of T-Cell Pharmaceuticals Private Limited are

Is T-Cell Pharmaceuticals Private Limited a listed company?

T-Cell Pharmaceuticals Private Limited is unlisted.

What is the capital structure of T-Cell Pharmaceuticals Private Limited?

The authorized capital of T-Cell Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available